Lina Choi
About Lina Choi
Lina Choi is a GMP Scientist at Andelyn Biosciences, specializing in gene therapy applications and clinical manufacturing processes. She holds a Bachelor's degree in Biochemistry from The Ohio State University and has experience in both upstream and downstream manufacturing in compliance with GMP regulations.
Work at Andelyn Biosciences
Lina Choi has been employed at Andelyn Biosciences as a GMP Scientist since 2021. In this role, she focuses on gene therapy applications within the clinical manufacturing facility. Her responsibilities include performing both upstream and downstream manufacturing processes while adhering to Good Manufacturing Practice (GMP) regulations. This ensures that the clinical manufacturing operations meet high standards necessary for the production of gene therapy products.
Education and Expertise
Lina Choi earned her Bachelor's degree in Biochemistry from The Ohio State University, completing her studies from 2016 to 2021. Her academic background has provided her with a solid foundation in biochemical principles, which she applies in her current role in gene therapy manufacturing. The knowledge gained during her education supports her expertise in clinical manufacturing processes.
Background in Research and Development
Prior to her current position, Lina Choi worked as a General Chemistry Research Assistant at The Ohio State University from 2019 to 2021. In this capacity, she contributed to various research projects, enhancing her understanding of chemical processes. Additionally, she completed a two-month internship at bioWORLD in 2020, where she gained experience in research and development. Her early career also includes a summer fellowship at the Boys & Girls Club in 2018, where she engaged in leadership activities.
Clinical Manufacturing Experience
Since July 2021, Lina Choi has been actively involved in clinical manufacturing facility operations, specifically focusing on the manufacturing and purification of Adeno Associated Viruses. These processes are critical for Phase I/IIa clinical trials, contributing to advancements in gene therapy. Her role encompasses ensuring compliance with GMP regulations, which is essential for maintaining the integrity and quality of clinical trial materials.